Patents Assigned to The Administrators of the Tulane
-
Patent number: 10538767Abstract: Treatment of tumors, especially breast cancer or glioblastoma tumors, by silencing RAB27A and/or TRAF3IP2, compositions and methods for same.Type: GrantFiled: November 26, 2018Date of Patent: January 21, 2020Assignee: The Administrators of the Tulane Educational FundInventors: Eckhard Alt, Reza Izadpanah
-
Patent number: 10537634Abstract: Immunogenic influenza hemagglutinin-derived peptide compositions described herein induce a specific therapeutic antibody response against influenza virus. The immunogenic peptide compositions comprise a segment from the fusion initiation region (FIR) domain of an influenza hemagglutinin protein bound to an immunogenic carrier protein, such as an influenza hemagglutinin (HA) protein (i.e., full length HA), and the like. The immunogenic peptide compositions described herein can be utilized to treat or prevent influenza infection and to prepare influenza-specific therapeutic antibodies that interfere with influenza virus-host cell membrane fusion. The peptide conjugates can be formulated in pharmaceutical compositions useful for broad spectrum treatment or prevention of influenza infections.Type: GrantFiled: October 31, 2018Date of Patent: January 21, 2020Assignees: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, AUTOIMMUNE TECHNOLOGIES, LLCInventors: Robert Francis Garry, Russell B. Wilson
-
Patent number: 10478407Abstract: Disclosed herein are topical compositions comprising a quaternary ammonium salt and optionally ammonium chloride and/or stabilized chlorine dioxide. Also disclosed herein are methods of reducing the severity and/or duration of a dermal and or mucosal infection such as herpes or shingles. Also disclosed herein are methods of preventing the spread of a viral infection such as HIV. Also disclosed herein are methods of treating a viral infection such as keratoconjunctivitis.Type: GrantFiled: February 22, 2019Date of Patent: November 19, 2019Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventor: Chad Roy
-
Patent number: 10472647Abstract: Episomally transfected primary mesenchymal stem cells (MSC) express a polypeptide consisting of an antigenic polypeptide (e.g., one or more polypeptides) relating to a pathogen (e.g., one or more virus, bacterium, or parasite). The antigenic polypeptide can have the amino acid sequence of a natural polypeptide from the pathogen or an amino acid sequence differing from the natural sequence by one or more conservative amino acid substitutions. Uses and method for treating or preventing infections with episomally transfected primary MSC also are described.Type: GrantFiled: November 15, 2013Date of Patent: November 12, 2019Assignee: The Administrators of the Tulane Educational FundInventors: Suzanne L. Tomchuck, Elizabeth B. Norton, Robert F. Garry, Bruce Bunnell, John D. Clements
-
Patent number: 10458985Abstract: This invention relates to a cell-surface marker for identifying MSC that are aging. This invention also relates to a method of screening MSCs of low proliferation potential and trilineage potential by removing CD264+ MSCs from the population.Type: GrantFiled: April 10, 2015Date of Patent: October 29, 2019Assignee: The Administrators of the Tulane Educational FundInventor: Kim C. O'Connor
-
Publication number: 20190307916Abstract: Otologic materials and methods are provided. For example, a cell-adhesive, biodegradable hydrogel scaffold loaded with time-released drugs for repairing chronic tympanic membrane perforations is disclosed, methods of making same and administering same are provided. This hydrogel may promote vascular in-growth and epithelial cell growth of the tympanic membrane with the purpose of closing the perforation and providing a barrier between the external and middle ear. The hydrogel is initially a liquid polymer that only gels upon exposure to specific conditions, such as exposure to light. This scaffold may simultaneously induce repair of the tympanic membrane while preventing or alleviating middle ear infection, thus filling a void in current tympanic membrane perforation therapies.Type: ApplicationFiled: June 23, 2019Publication date: October 10, 2019Applicant: The Administrators of the Tulane Educational FundInventors: Elaine Horn-Ranney, Parastoo Khoshakhlagh, Michael Moore, Jesse Ranney
-
Publication number: 20190282694Abstract: Immunoprotective primary mesenchymal stems cells (IP-MSC) which episomally express immunoreactive polypeptides that specifically target a pathogen (e.g., an infectious species of virus, bacterium, or parasite) or toxin are described herein. The immunoreactive polypeptides can be, e.g., full antibodies, single-chain antibodies (ScFV), Fab or F(ab)2 antibody fragments, diabodies, tribodies, and the like). Optionally IP-MSC are transfected to express one or more other immunomodulating polypeptides, e.g., a cytokine such as an interleukin (e.g., IL-2, IL-4, IL-6, IL-7, IL-9, and IL-12), an interferon (e.g., IFN?, IFN?, or IFN?), and the like, which can enhance the effectiveness of the immunoreactive polypeptides.Type: ApplicationFiled: May 30, 2019Publication date: September 19, 2019Applicants: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, AUTOIMMUNE TECHNOLOGIES, LLCInventors: Robert Francis Garry, Luis Manuel Branco, Bruce Alan Bunnell, Russell B. Wilson, Samuel E. Hopkins
-
Patent number: 10400237Abstract: The present disclosure provides compositions and methods of their use to impair angiogenesis in a patient to treat indications including, but not limited to, tumor growth, age-related macular degeneration, and metastasis. Also provided are compositions and methods for promoting angiogenesis in patients in need thereof.Type: GrantFiled: March 2, 2017Date of Patent: September 3, 2019Assignee: The Administrators of the Tulane Educational FundInventors: Shusheng Wang, Qinbo Zhou
-
Patent number: 10399280Abstract: A three dimensional (3D) printing system includes computer-executable instructions for obtaining a volumetric object representation file, parsing the volumetric object representation file into multiple layers, and for each layer, decomposing the layer into a sequence of continuous paths, aggregating non-continuous sets of tool paths with a single outer path and zero or more open or closed inner paths into islands, and generating one or more motion segments according to each island. Once generated, the motion segments may be aggregated to form a toolpath, which is used by the three dimensional printer to print a 3D model. Other embodiments may employ.Type: GrantFiled: April 28, 2017Date of Patent: September 3, 2019Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventors: Sam Lensgraf, Ramgopal Mettu
-
Patent number: 10357562Abstract: Immunoprotective primary mesenchymal stems cells (IP-MSC) which episomally express multiple immunoreactive polypeptides that specifically target a pathogen (e.g., an infectious species of virus, bacterium, or parasite) or toxin are described herein. The IP-MSC express two or more (e.g., 2 to about 100) immunoreactive polypeptides (e.g., full antibodies, single-chain antibodies (ScFV), Fab or F(ab)2 antibody fragments, diabodies, tribodies, and the like), and optionally one or more other immunomodulating polypeptides, e.g., a cytokine such as an interleukin (e.g., IL-2, IL-4, IL-6, IL-7, IL-9, and IL-12), an interferon (e.g., IFN?, IFN?, or IFN?), and the like, which can enhance the effectiveness of the immunoreactive polypeptides.Type: GrantFiled: July 17, 2015Date of Patent: July 23, 2019Assignees: The Administrators of the Tulane Educational Fund, Autoimmune Technologies, LLCInventors: Robert Francis Garry, Luis Manuel Branco, Bruce Alan Bunnell, Russell B. Wilson, Samuel E. Hopkins
-
Patent number: 10347476Abstract: Provided are synthetic dendrimer calibrants for mass spectrometry. The calibrants are distinguished by their relative ease and rapidity of synthesis, comparatively low cost, long shelf life, high purity, and amenability to batch synthesis as mixtures. The latter characteristic enables parallel preparation of higher molecular weight compounds displaying useful distributions of discrete molecular weights, thereby providing multi-point mass spectrometry calibration standards. Methods of making, tuning and using said calibrants are provided.Type: GrantFiled: May 21, 2013Date of Patent: July 9, 2019Assignee: The Administrators of the Tulane Educational FundInventor: Scott Grayson
-
Publication number: 20190115869Abstract: A spectrum splitting, transmissive concentrating photovoltaic (tCPV) module is proposed and designed for a hybrid photovoltaic-solar thermal (PV/T) system. The system may be able to fully utilize the full spectrum of incoming sunlight. By utilizing III-V triple junction solar cells with bandgaps of approximately 2.1 eV, 1.7 eV, and 1.4 eV in the module, ultraviolet (UV) and visible light (in-band light) are absorbed and converted to electricity, while infrared (IR) light (out-of-band light) passes through and is captured by a solar thermal receiver and stored as heat. The stored heat energy may be dispatched as electricity or process heat as needed. The tCPV module may have an overall power conversion efficiency exceeding 43.5% for above bandgap (in-band) light under a standard AM1.5D solar spectrum with an average concentration ratio of 400 suns. Passive and/or active cooling methods may be used to keep cells below 110° C.Type: ApplicationFiled: March 28, 2017Publication date: April 18, 2019Applicant: The Administrators of the Tulane Educational FundInventors: Matthew David Escarra, Qi Xy, Yaping Ji, Brian C. Riggs, Adam Ollanik, Kazi M. Islam, Daniel Codd, Vince Romanin, Nicholas David Farrar-Foley
-
Patent number: 10259975Abstract: The present invention relates to an easy, scalable method, relying on conventional and unconventional techniques, to incorporate tilt in the fabrication of synthetic polymer-based dry adhesives mimicking the gecko adhesive system. These dry, reversible adhesives demonstrate anisotropic adhesion properties, providing strong adhesion and friction forces when actuated in the gripping direction and an initial repulsive normal force and negligible friction when actuated in the releasing direction.Type: GrantFiled: December 1, 2016Date of Patent: April 16, 2019Assignee: The Administrators of the Tulane Educational FundInventors: Noshir Pesika, Kejia Jin
-
Publication number: 20190106473Abstract: Some embodiments of the invention include inventive compounds (e.g., compounds of Formula (I)) including but not limited to conjugates comprising FK-506 and ascomycin. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating. Further embodiments include methods for making the inventive compound. Additional embodiments of the invention are also discussed herein.Type: ApplicationFiled: March 23, 2017Publication date: April 11, 2019Applicant: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventors: Joseph A. FUSELIER, David H. COY
-
Patent number: 10251971Abstract: The present disclosure discloses compositions and methods for multipurpose disinfection and sterilization solutions broadly effective against multiple microbial pathogens. The present disclosure demonstrates broad spectrum antimicrobial activity against environmental and pathogenic amoeba, bacterial spores, vegetative bacteria, fungi, rickettsia, viruses, parasites and toxic microbial products. The multipurpose disinfection solutions of the present disclosure may be used alone or in combination for a variety of purposes, including disinfection of medical devices such as contact lenses, contact lens cases, surgical instruments, and dental instruments.Type: GrantFiled: September 2, 2016Date of Patent: April 9, 2019Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventors: Chad Roy, Rebecca Metzinger, Robert Reimers
-
Publication number: 20190054168Abstract: Immunogenic influenza hemagglutinin-derived peptide compositions described herein induce a specific therapeutic antibody response against influenza virus. The immunogenic peptide compositions comprise a segment from the fusion initiation region (FIR) domain of an influenza hemagglutinin protein bound to an immunogenic carrier protein, such as an influenza hemagglutinin (HA) protein (i.e., full length HA), and the like. The immunogenic peptide compositions described herein can be utilized to treat or prevent influenza infection and to prepare influenza-specific therapeutic antibodies that interfere with influenza virus-host cell membrane fusion.Type: ApplicationFiled: October 31, 2018Publication date: February 21, 2019Applicants: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, AUTOIMMUNE TECHNOLOGIES, LLCInventors: Robert Francis GARRY, Russell B. WILSON
-
Patent number: 10197500Abstract: Devices and methods for controlling the properties of chemical species during time-dependent processes. A device includes a reactor for containing one or more chemical species of a time-dependent process, an extraction pump for automatically and continuously extracting an amount of the one or more chemical species from the reactor, one or more detectors for measuring property changes of the one or more extracted chemical species and generating a continuous stream of data related to the one or more property changes to the one or more chemical species during a time interval, and a process controller configured to fit the continuous stream of data to a mathematical function to predict one or more properties of the one or more chemical species at a future time point and make one or more process decisions based on the prediction of one or more properties at the future time point.Type: GrantFiled: January 19, 2016Date of Patent: February 5, 2019Assignees: ADVANCED POLYMER MONITORING TECHNOLOGIES, INC., THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventors: Wayne Frederick Reed, Michael Felix Drenski
-
Patent number: 10178860Abstract: A mosquito trap includes a container having an open end and a composition positioned in the container. The composition comprises at least one active agent. The mosquito trap also includes an enclosure protruding above the open end of the container. The enclosure includes an opening to access an interior of the enclosure and the open end of the container, and at least one active agent.Type: GrantFiled: January 28, 2011Date of Patent: January 15, 2019Assignees: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, NORTH CAROLINA STATE UNIVERSITYInventors: Dawn Wesson, Charles Apperson, Loganathan Ponnusamy, Ning Xu, Coby Schal, Christopher Hoffmann
-
Patent number: 10166279Abstract: A mutant of an E coli heat-stable toxin (ST) having the following wild-type sequence: NSSNYCCELCCNPACTGCY wherein the mutant comprises a mutation selected from the group consisting of: A14H, A14T and N12T.Type: GrantFiled: February 20, 2014Date of Patent: January 1, 2019Assignees: Bergen Teknologioverføring, The Administrators of the Tulane Educational FundInventors: Pål Puntervoll, Halvor Sommerfelt, John Clements, James P. Nataro, Weiping Zhang, Arne M. Taxt
-
Publication number: 20180344905Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.Type: ApplicationFiled: August 11, 2018Publication date: December 6, 2018Applicant: The Administrators of the Tulane Educational FundInventors: Diane A. BLAKE, Vijay T. John, Ramesh Ayyala, Thiruselvam Ponnusamy